AI could take ‘years’ off the drug development process, says Bausch + Lomb CEO Brent Saunders

The day after reporting impressive Q1 earnings, Brent discussed the company’s performance with the “Squawk on the Street” team. He also shared how AI is being embedded into Bausch + Lomb operations, including the drug discovery process.